pagibaximab
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Introduction: Advances in modern medicine have given very low birth weight (VLBW) infants a better chance of survival; however…
BACKGROUND: Pagibaximab, a human chimeric monoclonal antibody developed against lipoteichoic acid, was effective against…
ABSTRACT Staphylococcal sepsis is a major cause of morbidity and mortality in very-low-birth-weight (VLBW) infants. A human…
BACKGROUND
Nosocomial infection is a major problem affecting the immediate health and long-term outcome of preterm and very low…
The ability to measure the opsonic activity of antibody may be critical in choosing among potential therapeutic candidates. It…